These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis. Salpeter SR West J Med; 1993 Nov; 159(5):560-4. PubMed ID: 8279152 [TBL] [Abstract][Full Text] [Related]
25. Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic. Nolan CM; Goldberg SV; Buskin SE JAMA; 1999 Mar; 281(11):1014-8. PubMed ID: 10086436 [TBL] [Abstract][Full Text] [Related]
26. Is isoniazid safe for liver transplant candidates with latent tuberculosis? Stucchi RS; Boin IF; Angerami RN; Zanaga L; Ataide EC; Udo EY Transplant Proc; 2012 Oct; 44(8):2406-10. PubMed ID: 23026607 [TBL] [Abstract][Full Text] [Related]
27. How safe is isoniazid? Thompson JE Med J Aust; 1978 Feb; 1(3):165-9. PubMed ID: 651734 [TBL] [Abstract][Full Text] [Related]
28. Letter: The competing risks of tuberculosis and hepatitis for adult tuberculin reactors. Moulding TS Am Rev Respir Dis; 1975 Oct; 112(4):581-2. PubMed ID: 1200492 [No Abstract] [Full Text] [Related]
30. [Hepatotoxicity of the combination of isoniazid-rifampicin in African children. Role of malnutrition and HB virus]. Gendrel D; Nardou M; Mouba JF; Gahouma D; Moussavou A; Boguikouma JB Arch Fr Pediatr; 1989 Nov; 46(9):645-8. PubMed ID: 2604523 [TBL] [Abstract][Full Text] [Related]
31. Underutilization of isoniazid chemoprophylaxis in tuberculosis contacts 50 years of age and older. A prospective analysis. Sorresso DJ; Mehta JB; Harvill LM; Bentley S Chest; 1995 Sep; 108(3):706-11. PubMed ID: 7656620 [TBL] [Abstract][Full Text] [Related]
32. Editorial: The prevention of tuberculosis. Gregg DB J S C Med Assoc; 1974 Apr; 70(4):122-4. PubMed ID: 4523827 [No Abstract] [Full Text] [Related]
33. Hepatotoxicity of antituberculosis therapy (rifampicin, isoniazid and pyrazinamide) or viral hepatitis. Türktaş H; Unsal M; Tülek N; Orüç O Tuber Lung Dis; 1994 Feb; 75(1):58-60. PubMed ID: 8161767 [TBL] [Abstract][Full Text] [Related]
34. Preventive therapy of tuberculosis. Brummer DL Annu Rev Med; 1974; 25():115-22. PubMed ID: 4596225 [No Abstract] [Full Text] [Related]
35. Hepatitis cases in isoniazid treated groups and in a control group. Riska N Bull Int Union Tuberc; 1976; 51(1):203-8. PubMed ID: 1030282 [No Abstract] [Full Text] [Related]
36. Isoniazid treatment for tuberculosis. Stadler ET; Steiner M N Engl J Med; 1971 Apr; 284(13):730-1. PubMed ID: 4993672 [No Abstract] [Full Text] [Related]
37. Monitoring preventive therapy patients for liver disease as well as compliance. Reichman LB Chest; 1975 Aug; 68(2):178-80. PubMed ID: 1149546 [TBL] [Abstract][Full Text] [Related]
38. Isoniazid-associated hepatitis. Edwards PQ Bull Int Union Tuberc; 1976; 51(1):209-12. PubMed ID: 1030283 [No Abstract] [Full Text] [Related]
40. Hepatitis on high dose isoniazid: reintroduction of the drug in severe tuberculous meningitis. Danielides IC; Constantoulakis M; Daikos GK Am J Gastroenterol; 1983 Jun; 78(6):378-80. PubMed ID: 6859018 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]